Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-08-01
著者
-
西尾 真
久留米大学医学部産科婦人科学教室
-
KOMAI KAN
Departments of Medicine and Obstetrics Gynecology, Kurume University School of Medicine
-
Fukui Akimasa
Department Of Life Sciences Graduate School Of Arts And Sciences University Of Tokyo
-
Komai Kan
Department Of Obstetrics And Gynecology Kurume University School Of Medicine
-
Ota Shunichiro
Department Of Obstetrics And Gynecology Kurume University School Of Medicine
-
NISHIO Shin
Department of Obstetrics and Gynecology, Kurume University School of Medicine
-
USHIJIMA Kimio
Department of Obstetrics and Gynecology, Kurume University School of Medicine
-
KAMURA Toshiharu
Department of Obstetrics and Gynecology, Kurume University School of Medicine
-
FUJIYOSHI Keizo
Department of Obstetrics and Gynecology, Kurume University School of Medicine
-
Nishio Shin
Department Of Obstetrics And Gynecology Kurume University School Of Medicine
-
Nishio Shin
Department Obstetrics And Gynecology Kurume University School Of Medicine
-
Ushijima K
Department Of Obstetrics And Gynecology Kurume University School Of Medicine
-
Ushijima Kimio
Department Of Obstetrics And Gynecology Kurume University School Of Medicine
-
Ushijima Kimio
Department Of Obstetrics And Gynecology Faculty Of Medicine Kurume University
-
Fukui Akimasa
Department Of Obstetrics And Gynecology Kurume University School Of Medicine
-
Fukui Akimasa
Department Of Life Science (biology) The University Of Tokyo
-
FUJIYOSHI Naoki
Department of Obstetrics and Gynecology, Kurume University School of Medicine
-
KAWANO Kouichiro
Department of Obstetrics and Gynecology, Kurume University School of Medicine
-
Kamura Toshihatu
Department Of Obstetrics And Gynecology Kurume University School Of Medicine
-
Kamura Toshiharu
Department Obstetrics And Gynecology Kurume University School Of Medicine
-
Kato Toshi
Department Of Obstetrics And Gynecology. School Of Medicine Kurume University
-
Kato Toshi
Department Of Obstetrics And Gynecology Kurume University School Of Medicine
-
Fujiyoshi Keizo
Department Of Obstetrics And Gynecology Kurume University School Of Medicine
-
Fujiyoshi Naoki
Department Of Obstetrics And Gynecology Kurume University School Of Medicine
-
Kawano Kouichiro
Department Of Obstetrics And Gynecology Kurume University School Of Medicine
-
USHIJIMA KIMIO
Department of Gynecology, Kurume University School of Medicine
関連論文
- 60 早期に発見された子宮癌肉腫の一症例
- P2-175 子宮頸癌放射線療法における細胞学的早期治療効果判定の試み(Group65 子宮頸部悪性腫瘍6,一般演題,第62回日本産科婦人科学会学術講演会)
- 309 分葉状内頸腺過形成(LEGH)成分を伴う子宮頸部腺癌の臨床病理学的意義(子宮頸部4(13),一般演題,第46回日本臨床細胞学会秋期大会)
- P2-204 再発子宮体癌における無治療期間は,二次化学療法の治療効果指標となりうるか?(Group68 子宮体部悪性腫瘍5,一般演題,第62回日本産科婦人科学会学術講演会)
- P3-3 子宮頸部腺癌手術後の臨床的検討(Group76 子宮頸部悪性腫瘍7,一般演題,第61回日本産科婦人科学会学術講演会)
- P3-10 子宮頸部扁平上皮癌における活性化Stat3(Signal transducer and activator of transcription 3)の発現は予後不良因子である(Group68 子宮頸部悪性腫瘍11,一般演題,第60回日本産科婦人科学会学術講演会)
- P1-220 卵巣癌におけるNDRG1発現と臨床病理学的検討(Group26 卵巣腫瘍2,一般演題,第62回日本産科婦人科学会学術講演会)
- オンコロジストが知っておくべき婦人科がんの知識--絨毛性疾患 (特集 婦人科がん/泌尿器がんの標準治療と今後の展望) -- (婦人科がんの標準治療と今後の展望)
- P3-3 子宮頸部腺癌におけるCap43の発現は血管新生及び予後との関連するか(Group67 子宮頸部悪性腫瘍10,一般演題,第60回日本産科婦人科学会学術講演会)
- P2-36 子宮頸部上皮内腫瘍(CIN)に対する子宮頸部円錐切除後に浸潤癌と診断される術前予測因子の検討(Group 38 子宮頸部悪性腫瘍8,一般講演,第60回産科婦人科学会学術講演会)
- 妊孕性温存治療の適応と実際 (特集 子宮がんの治療指針)
- 300 子宮頸部上皮内腫瘍(CIN)に対する子宮頸部円錐切除術後の病変残存に関する検討(子宮頸部4(10),一般演題,第46回日本臨床細胞学会秋期大会)
- 腹膜原発 endometrial stromal sarcoma の一例
- 症例提示(8)イホスファミド+パクリタキセル併用療法が著効した再発子宮がん肉腫の1例
- 標準治療無効, 耐性の再発, 再燃卵巣癌に対する経口エトポシド, 塩酸イリノテカン併用化学療法の有用性に関する検討(卵巣腫瘍III, 第57回日本産科婦人科学会学術講演会)
- 18-4.子宮頸癌化学放射線治療効果の予測 : 細胞診及び組織診による評価(第83群 子宮頸部悪性腫瘍8)(一般演題)
- 子宮体癌FIGO IIIc期の臨床病理学的検討
- 180 婦人科腹腔鏡手術における手術ロボット(AESOP system)の有用性の検討
- 硬化療法が奏効した卵巣癌術後巨大リンパ嚢胞の1例
- Scleroderma and Repeated Spontaneous Abortions Treated with Vitamin E — A Case Report —
- Weekly 1-h paclitaxel infusion in patients with recurrent endometrial cancer : a preliminary study
- Ovarian Endometrioid Adenocarcinoma Coexistent with Benign and Borderline Endometrioid Adenofibroma : A Case Report
- Anthropometric and Other Risk Factors for Ovarian Cancer in a Case-Control Study
- Transitional Cell Carcinoma of the Ovary : Report of Three Cases
- Improvement of Intraperitoneal Chemotherapy for Rat Ovarian Cancer Using Cisplatin-containing Microspheres
- IS-49 Spontaneously occurred ovarian teratoma in LT/Sv mouse : Is it a replica of human teratoma?
- Detection of Lymph Node Metastasis in Ovarian Carcinoma and Uterine Corpus Carcinoma by Preoperative Computerized Tomography or Magnetic Resonance Imaging
- Combination Treatment with Cisplatin and Schizophyllan for 7, 12-dimethylbenz(a)anthracene-Induced Rat Ovarian Adenocarcinoma
- HISTOLOGIC ORIGIN OF RAT OVARIAN CANCER INDUCED BY DIRECT APPLICATION OF 7,12-DIMETHYLBENZ(A)ANTHRACENE
- INTRASPLENIC GRAFTING OF 7,12-DIMETHYLBENZ (A) ANTHRACENCE-TREATED OVARIAN PIECE
- PROGNOSTIC SIGNIFICANCE OF GLIOBLASTOMA ELEMENT IN OVARIAN IMMATURE TERATOMA
- ADENOID CYSTIC CARClNOMA OF BARTHOLlN'S GLAND : A REVIEW OF THE LITERATURE AND REPORT OF A PATIENT
- A NEWER HYPERTHERMIC THERAPY WITH A BACTERIAL IMMUNOPOTENTIATOR (OK432) FOR CHEMOTHERAPY RESISTANT OVARIAN CANCER
- DEVELOPMENT OF OVARIAN TUMORS EXPERIMENTALLY STUDIED IN MICE BY ^Co-RAY IRRADIATION
- Expression of Tumor-rejection Antigens in Gynecologic Cancers
- Evidence that far infrared radiation promotes growth of Xenopus laevis
- Immunocytochemical study of activin type IB receptor (XALK4) in Xenopus oocytes
- Global and temporal regulation of gene expression in Xenopus kidney cells in response to presumed microgravity generated by 3D clinostats
- Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary
- Synthesis and release of activin and noggin by cultured human amniotic epithelial cells
- The Na^+, K^+-ATPase α subunit requires gastrulation in the Xenopus embryo
- Characterization of a gene respondent to clinorotation in Xenopus A6 cells
- Role of BMP-4 in the Inducing Ability of the Head Organizer in Xenopus laevis(Developmental Biology)
- Effects of rat Axin domains on axis formation in Xenopus embryos
- ANTITUMOR ACTIVITY OF CISPLATIN ANALOGS AGAINST MALIGNANT OVARIAN TUMOR XENOGRAFTS INTO NUDE MICE
- Induction of Cells Expressing Vascular Endothelium Markers from Undifferentiated Xenopus Presumptive Ectoderm by Co-treatment with Activin and Angiopoietin-2(Developmental Biology)
- ROLE OF CXCR4/SDF-1 SIGNALING IN XENOPUS GASTRULATION(Developmental Biology,Abstracts of papers presented at the 76^ Annual Meeting of the Zoological Society of Japan)
- MODIFICATION OF GENE EXPRESSION BY ACTIVIN-A IN XENOPUS PRESUMPTIVE ECTODERM(Developmental Biology,Abstracts of papers presented at the 75^ Annual Meeting of the Zoological Society of Japan)
- KRUKENBERG TUMORS OF THE OVARY : A CLINICOPATHOLOGIC ANALYSIS OF 112 CASES
- MALIGNANT DEGENERATION OF BENIGN CYSTIC TERATOMAS OF THE OVARY
- Comparison of the Anterior Colporrhaphy Procedure and the Marshall-Marchetti-Krantz Operation in the Treatment of Stress Urinary Incontinence among Women
- Control of embryonic body axis formation in vitro in Xenopus early development(Developmental Biology)(Proceeding of the Seventy-Third Annual Meeting of the Zoological Society of Japan)
- Cloning and analysis of Xnopus Axam, a novel Wnt signaling related molecule(Developmental Biology)(Proceeding of the Seventy-Third Annual Meeting of the Zoological Society of Japan)
- CHEMOTHERAPY OF MALIGNANT OVARIAN TUMORS; THERAPEUTIC RESULTS OF IFOSFAMIDE
- ESTABLISHMENT AND MORPHOLOGIC CHARACTERIZATION OF CELL LINE (DMBA-OC-1) FROM 7,12- DIMETHYLBENZ (a) ANTHRACENE-INDUCED RAT OVARIAN CARCINOMA
- Evidence-based guidelines for treatment of cervical cancer in Japan : Japan Society of Gynecologic Oncology (JSGO) 2007 edition
- CHARACTERIZATION OF TRANSPLANT GENERATIONS OF PRIMARY RAT ADENOCARCINOMA AND SOME CHEMOTHERAPEUTIC OBSERVATIONS
- IS-30 Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy(Group4 Oncology2,International Session)
- P2-28-7 婦人科悪性腫瘍終末期における緩和的人工肛門造設に関する検討(Group130 婦人科悪性腫瘍・その他,一般演題,第63回日本産科婦人科学会学術講演会)
- P2-12-12 子宮頸癌における術後放射線照射リスク因子の術前評価の検討(Group91 子宮頸部腫瘍・治療3,一般演題,第63回日本産科婦人科学会学術講演会)
- P2-23-29 プラチナ感受性再発卵巣がんに対するbiweeklyドセタキセル/カルボプラチン療法第二相試験 : West Japan Gynecologic Oncology Group [WJGOG] 041(Group123 悪性卵巣腫瘍・治療3,一般演題,第63回日本産科婦人科学会学術講演会)
- P2-19-29 パクリタキセルの正常卵巣への影響の検討(Group111 悪性卵巣腫瘍・基礎2,一般演題,第63回日本産科婦人科学会学術講演会)
- Efficacy of Selective Venous Sampling to Localize a Small Ovarian Androgen-Producing Tumor
- 4-16.Expression of Y Box-binding Protein-1, P-glycoprotein, and topoisomerase IIα as a Prognostic Marker for Survival in Epithelial Ovarian Cancer(Session 6 Oncology 6)
- Molecular Pathology of Atypical Polypoid Adenomyoma of the Uterus(Session6 Oncology6)
- 子宮・卵巣がん (特集 外来診療に有用な腫瘍マーカーの知識) -- (各種疾患の腫瘍マーカー)
- 子宮体がん (がん治療最前線--米国癌学会(ASCO)のトピックスを中心に) -- (臓器部位別の治療戦略)
- IS-51 Synthetic Micro RNA Designed to target Glioma-Associated Antigen-1 Transcription Factor (Gli-1) inhibits proliferation in Ovarian cancer cells(Group6 Oncology3,International Session)
- P1-IS-30 The polysomal RNA from ovarian cancers can stimulate tumor antigen-specific immunity.
- Sensitivity of high-TCR-density CD8^+ cells to a CH_2appended to tumor antigen determines their differentiation or death(Oncology 12)
- Primary adenocarcinoma of the vagina successfully treated with neoadjuvant chemotherapy consisting of paclitaxel and carboplatin
- OVARIAN TUMORS IN CHILDREN AND ADOLESCENTS LESS THAN 20 YEARS AGE
- CLINICAL STUDY ON THE TREATMENT OF MALIGNANT OVARIAN TUMOR : PARTICULARLY THE CLINICAL MANAGEMENT OF DYSGERMINOMA AND COMMON EPITHELIAL CARCINOMA
- Pulmonary Metastasis of Endometrial Stromal Sarcoma
- 卵巣がんの分子標的治療 (特集 婦人科がんの最新の薬物療法)
- Desmoplastic small round cell tumor in the ovary : Report of two cases and literature review
- P3-4-3 HPV-VLP16/18L1に対する液性免疫応答の検討(Group116 子宮頸部腫瘍・HPV2)
- Precise evaluation of chemotherapy-induced peripheral neuropathy using the visual analogue scale : a quantitative and comparative analysis of neuropathy occurring with paclitaxel-carboplatin and docetaxel-carboplatin therapy
- P3-7-6 予定していた広汎子宮全摘術を術中所見により変更することの妥当性(Group119 子宮頸部腫瘍・治療3)
- K2-4-5 進行・再発卵巣粘液性腺癌に対するSOX(S-1/Oxaliplatin)療法の第II相試験(高得点演題9 婦人科腫瘍学3,一般演題,公益社団法人日本産科婦人科学会第65回学術講演会)
- P1-3-6 婦人科癌の脳転移139症例の臨床病理学的検討(Group 3 悪性腫瘍全般・治療・再発2,一般演題,公益社団法人日本産科婦人科学会第65回学術講演会)
- K3-5-1 「プラチナ感受性」の概念は再発子宮体癌に適用可能か?(高得点演題17 婦人科腫瘍学6,一般演題,公益社団法人日本産科婦人科学会第65回学術講演会)
- Serous Adenocarcinofibroma of the Ovary. Report of Two Cases and Review of the Literature.:Report of Two Cases and Review of the Literature
- Sertoli-stromal Cell Tumor Containing Metastatic Lung Cancer Tissue.
- An experimental model for advanced ovarian cancer.
- Characterization of transplant generations of primary rat adenocarcinomas.
- P2-1-2 子宮頸部上皮内腫瘍の局所治療後のHPV16型および18型持続感染は再治療のリスクが高い(Group 53 CIN・その他・診断・治療1,一般演題,公益社団法人日本産科婦人科学会第65回学術講演会)
- A Sequential Immunosuppressive Treatment with Mizoribin (Bredinin) plus Cyclosporin A on the Subrenal Capsule Assay.
- Minimal Deviation Adenocarcinoma (Adenoma Malignum) of the Uterine Cervix Associated with Mucinous Ovarian Carcinoma.
- Optimal Timing of a Second-Look Operation for Advanced Epithelial Ovarian Cancer.
- Experimental Intraperitoneal Administration of Cisplatin-activated Carbon for Rat Ovarian Adenocarcinomas.
- Reassessment of Second Look Operation for Epithelial Ovarian Cancer.
- 子宮頸癌の化学療法 : 進行・再発癌に対して (特集 子宮頸癌治療の変遷と今後の展開)
- P1-3-2 Visual Analogue Scale (VAS)により化学療法に伴う末梢神経障害はさらに詳細に評価できる(Group 3 悪性腫瘍全般・治療・再発2,一般演題,公益社団法人日本産科婦人科学会第65回学術講演会)
- GnRH Agonist Acts as Ovarian Protection in Chemotherapy Induced Gonadotoxicity: An Experiment Using a Rat Model
- P2-52-2 子宮頸癌放射線治療症例における治療感受性判定と予後について(Group 90 子宮頸部腫瘍・治療2,一般演題,公益社団法人日本産科婦人科学会第66回学術講演会)
- P2-18-9 卵巣癌の臨床進行期分類(FIGO1988分類)は後腹膜リンパ節転移を過大評価しているか?(Group 56 卵巣腫瘍・症例検討,一般演題,第66回学術講演会)
- MW-1-2 子宮頸部「胃型腺癌」の後方視的研究(ミニワークショップ1 婦人科腫瘍・臨床試験,一般演題,公益社団法人日本産科婦人科学会第66回学術講演会)
- P3-41-4 子宮頸癌骨転移に対する治療法・予後についての後方視的研究(Group 138 子宮頸部腫瘍・治療4,一般演題,公益社団法人日本産科婦人科学会第66回学術講演会)
- P2-56-6 卵巣明細胞腺癌における酸化ストレス回避機構に関する検討(Group 94 卵巣腫瘍・基礎5,一般演題,公益社団法人日本産科婦人科学会第66回学術講演会)